Brand Round UP (3) Oncolys Bioventure Oncolys Biopharma, which develops anticancer drugs using viruses, is attracting attention. The company is developing a drug that uses a virus to selectively infect and kill cancer cells. It is currently in phase 1 clinical trials in the United States and Japan. The stock price has risen sharply due to the announcement of the start of clinical trials in Japan.